Drug Interactions With Non–Vitamin K Oral Anticoagulants
- 27 February 2018
- journal article
- letter
- Published by American Medical Association (AMA) in JAMA
- Vol. 319 (8) , 830
Abstract
To the Editor Among 91 330 patients with nonvalvular atrial fibrillation in Taiwan, the use of NOACs with concurrent amiodarone, fluconazole, rifampin, or phenytoin was associated with significantly increased risk of major bleeding.1 We are challenged to identify a biologically plausible explanation for the increased bleeding risk observed with phenytoin and rifampin.Keywords
This publication has 4 references indexed in Scilit:
- Association Between Use of Non–Vitamin K Oral Anticoagulants With and Without Concurrent Medications and Risk of Major Bleeding in Nonvalvular Atrial FibrillationJAMA, 2017
- Interactions between non-vitamin K oral anticoagulants and antiepileptic drugsEpilepsy Research, 2016
- Effect of Rifampin on the Pharmacokinetics of Apixaban, an Oral Direct Inhibitor of Factor XaAmerican Journal of Cardiovascular Drugs, 2016
- Epileptic seizures in intracerebral haemorrhage.Journal of Neurology, Neurosurgery & Psychiatry, 1989